Professor of Medicine, SUNY Stony Brook
Endocrinology
Dr. Marie Gelato, MD
|
|
Give Review
Marie Gelato practices Endocrinology. She went to UMDNJ-Robert Wood Johnson Medical School. She received awards:"Top Doctors: New York Metro Area", "Newsday - Top Doctors on Long Island", "New York Magazine: Top Doctors" and "Top MD". Marie Gelato, MD is a published doctor and has 100 publications published. The lastest was: 'Albumin synthesis and bone collagen formation in human immunodeficiency virus-positive subjects: differential effects of growth hormone administration.' She is registered with Medicare.
Publications
- Design features of the Diabetes and Periodontal Therapy Trial (DPTT): A multicenter randomized single-masked clinical trial testing the effect of nonsurgical periodont...
- Peripheral fat loss and decline in adipogenesis in older humans.
- Why clinical research centers?
- Feeding acutely stimulates fibrinogen synthesis in healthy young and elderly adults.
- Influence of age on the association of retinol-binding protein 4 with metabolic Syndrome.
- Endothelial adhesion molecules are associated with inflammation in subjects with HIV Disease.
- Wall suction applied to needle muscle biopsy - a novel technique for increasing sample size.
- Limb fat to trunk fat ratio in elderly persons is a strong determinant of insulin resistance and adiponectin levels.
- Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 Diabetes.
- Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 Diabetes: response to Cho et al.
- Response of albumin synthesis to oral nutrients in young and elderly subjects.
- The increase in human muscle protein synthesis induced by food intake is similar when assessed with the constant infusion and flooding techniques.
- Insulin and carbohydrate dysregulation.
- Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution.
- Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone: a pilot study.
- Cushing's Disease after surgical resection and radiation therapy for nonfunctioning pituitary adenoma.
- Soluble tumour necrosis factor alpha receptor 2, a serum marker of resistance to the anabolic actions of growth hormone in subjects with HIV Disease.
- Importance of the high-molecular-mass isoform of adiponectin in improved insulin sensitivity with rosiglitazone treatment in HIV Disease.
- Effect of ritonavir and atazanavir on human subcutaneous preadipocyte proliferation and differentiation.
- Rosiglitazone-Mediated Effects on Skeletal Muscle Gene Expression Correlate with Improvements in Insulin Sensitivity in Individuals with HIV-Insulin Resistance.
- Growth hormone-insulinlike growth factor I and immune function.
- Chromium picolinate for insulin resistance in subjects with HIV Disease: a pilot study.
- Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
- Chronic loss of subcutaneous adipose tissue in HIV-associated lipodystrophy may not be associated with accelerated apoptosis.
- Loss of subcutaneous adipose tissue in HIV-associated lipodystrophy is not due to accelerated apoptosis.
- Osteopenia in patients with HIV infection is not associated with elevated sTNFR2 levels.
- Chromium picolinate improves insulin sensitivity in obese subjects with Polycystic ovary syndrome.
- Lymphocyte protein synthesis is increased with the progression of HIV-associated Disease to AIDS.
- Hormonal regulation of protein Metabolism in relation to nutrition and disease.
- IGFBP-3. Functional and structural implications in aging and wasting Syndromes.
- Responsiveness of muscle protein synthesis to growth hormone administration in HIV-infected individuals declines with severity of Disease.
- Transient exposure of human myoblasts to Tumor necrosis factor-alpha inhibits serum and insulin-like growth factor-I stimulated protein synthesis.
- Acute alterations in growth hormone-insulin-like growth factor axis in humans injected with endotoxin.
- Hypothalamic versus pituitary dysfunction in Down''s Syndrome as cause of growth retardation.
- Effect of short-term fasting on free/dissociable insulin-like growth factor I concentrations in normal human serum.
- IL-6 stimulation of insulin-like growth factor binding protein (IGFBP)-1 production.
- Proteolysis of insulin-like growth factor-binding protein-3 in human immunoDeficiency virus-positive children who fail to thrive.
- Wasting in the acquired immune deficiency Syndrome is associated with multiple defects in the serum insulin-like growth factor system.
- Aging and immune function: a possible role for growth hormone.
- Regulation of the insulin-like growth factor system by insulin in burn patients.
- Endocrine effects of erythropoietin.
- Pituitary and hypothalamic insulin-like growth factor-I (IGF-I) and IGF-I receptor expression in food-deprived rats.
- The serum insulin-like growth factor-II/mannose-6-phosphate receptor in normal and diabetic pregnancy.
- Alterations in hepatic production and peripheral clearance of IGF-I after endotoxin.
- Alterations in the insulin-like growth factor system in trauma patients.
- Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent Diabetes mellitus.
- Phosphorylation of insulin-like growth factor binding protein-1 in patients with insulin-dependent Diabetes mellitus and severe trauma.
- Insulin-like growth factor-I and insulin-like growth factor binding proteins in the Zucker fatty rat: a case for differential tissue regulation.
- Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells.
- Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin.
- Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by Tumor necrosis factor.
- Follicular variant of papillary carcinoma with hyperThyroidism.
- Effects of a growth hormone releasing factor in man.
- Direct effect of the luteinizing hormone releasing hormone analog D-Trp6-Pro9-Net-LHRH on rat Testicular steroidogenesis.
- The effects of prolactin on rat Ovarian function.
- Dose-response relationships for the effects of growth hormone-releasing factor-(1-44)-NH2 in young adult men and women.
- Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone Deficiency.
- Production of monoclonal antibodies against human growth hormone releasing hormone and their use in an enzyme-linked immunosorbent assay (ELISA)
- Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH Deficiency.
- Responses of growth hormone (GH) and somatomedin-C to GH-releasing hormone in healthy aging men.
- Growth hormone releasing hormone.
- The insulin-like growth factor II/mannose-6-phosphate receptor is present in monkey serum.
- The insulin-like growth factor II/mannose-6-phosphate receptor is present in fetal and maternal sheep serum.
- Growth hormone responses to growth hormone-releasing hormone in Hand-Schüller-Christian Disease.
- Insulin-like growth factor-II: possible local growth factor in pheochromocytoma.
- Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.
- Pituitary insulin-like growth factor-I content and gene expression in the streptozotocin-diabetic rat: evidence for tissue-specific regulation.
- Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
- Heterogeneity of binding subunits of the human 150K insulin-like growth factor binding protein.
- Hormonal regulation of rat hypothalamic neuropeptide mRNAs: effect of hypophysectomy and hormone replacement on growth-hormone-releasing factor, somatostatin and the i...
- Interaction of growth hormone-releasing hormone with the insulin-like growth-factors during prenatal development in the rat.
- Differential tissue regulation of the insulin-like growth factors in rats bearing the MStT/W15 pituitary Tumor.
- Differential tissue regulation of insulin-like growth factor binding proteins in experimental Diabetes mellitus in the rat.
- Adrenal involvement in the timing of puberty in female rats: interaction with serum prolactin levels.
- Growth hormone-releasing hormone: therapeutic perspectives.
- Bromocriptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat.
- The effects of prolactin on rat Testicular steroidogenic enzyme activities.
- Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH Deficiency.
- Growth hormone responses to continuous infusions of growth hormone-releasing hormone.
- Effects of growth hormone-releasing factor on growth hormone secretion in acromegaly.
- Association of severe insulin resistance with both loss of limb fat and elevated serum Tumor necrosis factor receptor levels in HIV lipodystrophy.
- The growth hormone/insulin-like growth factor axis in critical illness.
- Insulin-like growth factor system in patients with HIV infection: effect of exogenous growth hormone administration.
- Albumin synthesis and bone collagen formation in human immunoDeficiency virus-positive subjects: differential effects of growth hormone administration.
- Direct effect of the luteinizing hormone releasing hormone analog D-Trp6-Pro9-Net-LHRH on rat Ovarian steroidogenesis.
- Therapy for human autoimmune uveitis with low-dose cyclosporine plus bromocriptine.
- Lymphocyte subset distribution and natural killer activity in growth hormone Deficiency before and during short-term treatment with growth hormone releasing hormone.
- Antigonadotrophic effect of prolactin in adult castrated and in immature female rats.
- Effects of estrogen and testosterone on specific prolactin binding in the kidneys and Adrenal of rats.
- Prolactin binding activity on the crop sacs of juvenile, mature, parent and prolactin-injected pigeons.
- Serum prolactin levels and prolactin binding activity in Adrenals and kidneys of male rats after dehydration, salt loading, and unilateral nephrectomy.
- Effects of Thyroid and ovaries on prolactin binding activity in rat liver.
- Oestrogens and prolactin as possible regulators of puberty.
- Evidence for a positive feedback action of estrogen on LH secretion in immature female rats.
- Effects of castration, testosterone, estradiol, and prolactin on specific prolactin-binding activity in ventral prostate of male rats.
- Mechanisms of pentobarbital actions on prolactin release.
- Inhibition of prolactin secretion by cholinergic drug.
- Effects of haloperidol on serum and pituitary prolactin, LH and FSH, and hypothalamic PIF and LRF.
- Editorial: The rational use of growth hormone in HIV-infected patients.
Schools
Michigan State University College Of Human Medicine
Dartmouth
Rutgers University
National Institute Of Health
Conditions Treated
- Abnormal Thyroid
- Adrenal Insufficiency
- Calcium Metabolism Disorders
- Diabetes Type 1
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- Top Doctors: New York Metro Area
- Newsday - Top Doctors on Long Island
- New York Magazine: Top Doctors
- Top MD
Education
-
National Institutes of Health Clinical Center -
UMDNJ-Robert Wood Johnson Medical School -
Dartmouth-Hitchcock Medical Center -
Michigan State University College of Human Medicine
Hospital
-
Stony Brook University Medical Center
Drug Facts
| NPI NUMBER | 1730114570 | |
| NPPES Provider LastName | GELATO | |
| NPPES Provider FirstName | MARIE | |
| NPPES Provider ZIPCode | 11733 | |
| NPPES Provider State | NY | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 519.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730114570 |
| Last Name Of The Provider | GELATO |
| First Name Of The Provider | MARIE |
| View All |
Similar Doctors
|
|
Dr. Irwin J. Kurland, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anoop Kapoor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Igor Kravets, MD
This Doctor is OpenDoctor Recommended.
|